February 24, 2017 / 4:32 PM / 10 months ago

BUZZ-IntelliPharmaCeutics International Inc: FDA approves generic diabetes drug

** Generic drugmaker’s U.S.-listed shares up 20 pct at $2.58 in morning trade

** Stock rises as much as 31.2 pct to $2.82; biggest intraday pct gain in more than 4 months

** Says wins U.S. Food and Drug Administration approval for launch of generic version of Bristol-Myers Squibb’s diabetes drug glucophage

** Says “actively evaluating options to realize commerical returns from this new approval”

** More than 4.5 mln shares traded, 19.2x 30-day moving avg

** Up to Thursday’s close, stock had lost nearly 1/4 of its value YTD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below